남성 불임증 시장 보고서 : 검사 종별, 치료법, 유통경로, 최종사용자, 지역별(2026-2034년)

The global male infertility market size was valued at USD 4.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.4 Billion by 2034, exhibiting a CAGR of 4.28% during 2026-2034. Europe currently dominates the market. The rise in the prevalence of male infertility, emerging trend of delayed parenthood, notable technological advancements, changing lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

The global market is driven by the rising prevalence of infertility among men due to lifestyle changes, stress, and exposure to environmental toxins. According to a report by the National Library of Medicine, it has been estimated that in North America, 4.5% to 6% of the male infertility rates are seen, whereas the rate is higher in Australia, at about 9%. In the Eastern European regions, the rate ranges between 8% and 12%. Bayasgalan et al. showed that only 25.6% of infertility cases resulted from male factors. Another study by Thonneau et al. showed that 20% of cases of infertility were due exclusively to male factors in France. Along with this, continual advancements in diagnostic technologies, such as genetic testing and advanced semen analysis, are enhancing the accuracy and early detection of male infertility. Moreover, growing awareness of fertility treatments and increasing acceptance of assisted reproductive technologies (ART) further support the male infertility market growth. Besides this, favorable government initiatives, rising healthcare spending, and the proliferation of fertility clinics globally contribute to the expansion of the market.

The United States stands out as a key regional market, primarily driven by the increasing adoption of lifestyle interventions and medical advancements tailored to address reproductive health issues. The growing emphasis on proactive healthcare is encouraging men to seek early diagnosis and treatment for infertility. Apart from this, the rise of private and public sector initiatives aimed at improving reproductive health awareness is also bolstering market demand. Furthermore, a significant increase in research funding for male infertility and the growing prevalence of chronic conditions, such as obesity and diabetes, linked to infertility, are major contributors to market growth. On 17th September 2024, Wayne State University received a USD3.08 Million NIH grant to study how environmental factors, particularly exposure to endocrine-disrupting phthalates, impact male fertility. Led by Dr. Richard Pilsner, the research focuses on identifying seminal plasma biomarkers linked to reproductive outcomes, aiming to improve fertility interventions and advance understanding of environmental health's role in reproduction. Moreover, expanding access to specialized fertility clinics enhances US male infertility market share.

Male Infertility Market Trends:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high-stress levels, have collectively contributed to a rise in fertility issues among men. According to the American Psychological Association (APA), in 2023, 4.8 out of 10 men reported having a higher average level of stress. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The emerging trend of delaying parenthood gained momentum due to changing societal norms and career aspirations. According to the Centers for Disease Control and Prevention, between 2015 to 2019, 76.5% of the men aged 40-49 had fathered a child. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a rise in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis allow for a more detailed assessment of sperm quality. Advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), also improve the possibility of successful fertilization. These technologies increase precision in identifying underlying causes of infertility and offer healthcare professionals a wider range of tools to tailor treatment plans. As technology transforms, it's likely to greatly improve results and be an important player in the growth of the male infertility market by giving patients more personalized and effective solutions.

Widespread Utilization of Assisted Reproductive Technology (ART)

The utilization of assisted reproductive technology (ART) has witnessed significant growth in addressing male infertility, with intracytoplasmic sperm injection (ICSI) emerging as one of the most effective techniques. ICSI, a specific type of in vitro fertilization (IVF), comprises the direct injection of a single sperm into an egg, facilitating fertilization even in instances of significant male factor infertility, like low sperm count, inadequate motility, or abnormal morphology. This method has gained prominence due to its high success rates and its ability to overcome barriers that previously limited natural conception. Improvements in sperm retrieval methods, including testicular sperm extraction (TESE) and microsurgical epididymal sperm aspiration (MESA), have significantly increased the success of ICSI, offering options for men experiencing azoospermia. The increasing accessibility and refinement of ART procedures are playing a pivotal role in expanding reproductive options for couples facing male infertility challenges. In 2024, SpOvum announced the launch of its advanced AI-powered platform, SpOvum ARTPT, aimed at advancing patient interaction in the field of Assisted Reproductive Technology (ART).

Male Infertility Industry Segmentation:

Analysis by Test Type:

• Sperm Agglutination
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Computer Assisted Semen Analysis
• Sperm Penetration Assay
• Others

DNA fragmentation technique stands as the largest component in 2025. DNA fragmentation testing is gaining prominence as the most popular test type in the male infertility diagnostics market due to its superior ability to assess sperm quality at a molecular level. It is different from conventional semen analysis as it examines the integrity of sperm DNA, which is essential for the successful fertilization and development of an embryo. This rising trend is due to the reliability of identifying underlying causes of infertility that standard tests may fail to detect. Growing awareness of the importance of DNA integrity among healthcare providers and patients contributes further to its market demand. Technology has also advanced, making DNA fragmentation testing more accessible and efficient.

Analysis by Treatment:

• Medication
• Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery leads the market in 2025. ART, which contains techniques such as IVF and ICSI, gives a couple the chance to overcome almost all types of fertility problems, including male-factor infertility. Success rates, among others with ART, have also made this a sought option. On the other hand, varicocele surgery has been one of the established surgical therapies for varicocele, which are dilated veins of the scrotum. The primary function of these veins will affect the production of sperm and quality due to its interference. Corrective varicocele surgery tends to enhance the flow of blood, which potentially can improve sperm motility and production. This procedure has demonstrated positive results in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's landscape.

Analysis by Distribution Channel:

• Hospitals Pharmacies
• Pharmacies and Drug Stores
• Online Pharmacies

Hospitals pharmacies lead the market in 2025. Hospitals provide a one-stop, comprehensive facility for specialized diagnostics, medical expertise, and treatment options. This makes them the ideal destination for patients who may require comprehensive evaluation, consultations by fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. They play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, they offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Analysis by End User:

• Hospitals and Clinics
• Fertility Centers
• Research Institutes
• Others

Fertility centers lead the market in 2025. These centers focus entirely on giving a comprehensive series of treatments uniquely suited to infertile men and women and to infertile couples. Fertility centers contain teams of skilled reproductive endocrinologists, urologists, and embryologists, among other experts providing diagnosis evaluations, tailor-made treatment plans, and even assisted reproductive technologies under the same roof. This is the approach, through which fertility centers operate, give an integrated kind of diagnosis, analysis, and innovative treatments for male infertility. These centers provide an ideal setting that deals with all aspects of emotional and physiological concerns related to infertility problems. The availability of current technology, latest procedures, and a complete understanding about the male reproductive health allows fertility centers to become more prominent in the choices as the most preferred option for providing guidance and achieving successful cases against male infertility.

Regional Analysis:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2025, Europe accounted for the largest market share. The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. The changing socio-cultural dynamics have increased awareness and acceptance of fertility issues, leading to more individuals and couples opting for medical intervention. In European countries, reproductive health is also given much importance, and comprehensive healthcare coverage is provided, thus increasing the accessibility of fertility treatments to a larger population. The ageing of the population throughout the region is also contributing to the increasing demand for ART since late parenthood is becoming prevalent. Additionally, Europe's strong presence in medical research and development (R&D) enhances innovation in male infertility treatment, which attracts patients locally and internationally seeking the best option.

Key Regional Takeaways:

United States Male Infertility Market Analysis

The male infertility market in the United States is growing due to the increasing prevalence of obesity and sedentary lifestyles, which are directly impacting sperm health and fertility. According to the Centers for Disease Control and Prevention, the prevalence of obesity among adults were 40.3% between august 2021 and 2023. Moreover, the prevalence was 39.2% among men. Additionally, fertility clinics are rapidly expanding their service portfolios, integrating advanced technologies such as microfluidic sperm sorting and AI-assisted diagnostics which is augmenting the market growth. Furthermore, health insurance companies are progressively including male infertility treatments in their coverage plans thereby increasing affordability. Similarly, the rising use of anabolic steroids among athletes and bodybuilders are contributing to fertility issues, fueling demand for corrective treatments. Also, research institutions are actively investing in genetic testing to address unexplained infertility cases which is bolstering the market growth. Meanwhile, the growing social acceptance of discussing male reproductive health is encouraging more individuals to seek timely medical intervention. This, in turn, is impelling the market growth.

Asia Pacific Male Infertility Market Analysis

The male infertility market in Asia Pacific is witnessing progress with the adoption of cost-effective in-vitro fertilization procedures appropriate for middle-income families. Besides this, governments are promoting awareness campaigns emphasizing the evaluation of male fertility, as the stigma surrounding infertility places blame on women. With increasing environmental toxins and industrial pollutants in urban areas, which have been proven to decrease sperm quality, demand is building for therapeutic solutions. According to reports, in 2019, India ranked as the fifth most polluted country globally and accounted for 14 of the 20 cities with the highest PM 2.5 air pollution levels. Furthermore, the rise of medical tourism, particularly in countries such as India and Thailand, is making advanced fertility treatments accessible at competitive prices, thereby positively influencing the market.

Europe Male Infertility Market Analysis

In Europe, the market is changing with the implementation of stringent workplace health regulations to limit exposure to reproductive toxins. As per the male infertility market report, pharmaceutical companies are rolling out new medications addressing hormonal imbalances linked to infertility, supported by favorable regulatory frameworks. Additionally, lifestyle shifts, including delayed family planning and increased alcohol consumption, are escalating infertility rates, prompting a rise in medical consultations. According to the government of the UK, in 2022, 56% of adults in England consumed alcohol. Moreover, men drank more than that of women. 61% of men and 51% of women consumed alcohol across the country. Apart from this, fertility centers are using non-invasive diagnostic techniques such as high-resolution ultrasound that are patient-friendly and, therefore, act as a catalyst in the market expansion. In addition, governments in the region are funding research in cryopreservation technologies that are currently in vogue among men who delay parenting. With these factors at play, the demand in the market is going up in the region.

Latin America Male Infertility Market Analysis

The Latin America male infertility market is expanding with the rising demand for low-cost fertility treatments, making them accessible to a broader population. Moreover, increased pesticide and agrochemical exposure in rural areas is driving awareness and treatment for sperm-related issues. Furthermore, rapid urbanization is contributing to lifestyle-related fertility challenges, prompting the adoption of personalized fertility solutions. According to the Central Intelligence Agency, in 2021, 87.3% of the total population in Brazil is urbanized. Due to these, the demand for male infertility market is expanding across the region.

Middle East and Africa Male Infertility Market Analysis

The Middle East and Africa market for male fertility is growing as the socio-cultural factors that created barriers to talking about infertility are slowly coming down. The rising incidences of varicocele, which were not always diagnosed due to ignorance regarding the symptoms, are being treated through minimally invasive surgery. Climatic conditions with extreme heat also resulted in low sperm quality, leading to increased demand for sophisticated diagnostic solutions. According to the NASA Earth Observatory, on June 6, 2021, Sweihan in the UAE recorded a temperature of 51.8°C (125.2°F), marking the highest temperature ever documented in the country for the month of June.

Competitive Landscape:

According to male infertility market report, the leading players are investing in research and development (R&D) to design new and enhanced diagnostic tools, treatments, and technologies for male infertility. The innovation is focused on techniques of sperm analysis, new medication, and assisted reproductive technology to ensure improved results for the treatment. Some leading players usually engage academic institutes, research institutions, and healthcare providers to share ideas and experiences with one another in their bid to enable innovations in diagnostics and treatments for male infertility. These collaborations inspire synergistic efforts to solve complex issues with the provision of holistic solutions. In addition to this, as raising awareness about male infertility becomes important, industry leaders participate in educational activities. Online platforms, seminars, and health care professional training sessions serve as information provision mediums for them. Thus, they work toward understanding the condition and ensure appropriate interventions at the right time. Moreover, key players are involved in strategic expansion endeavors by tapping into emerging markets having rising demand for the treatment of male infertility. While expanding their reach, they ensure that a larger section of patients can access leading diagnostic and therapeutic facilities.

The report provides a comprehensive analysis of the competitive landscape in the male infertility market with detailed profiles of all major companies, including:

• Andrology Solutions
• CaerusBiotech
• CinnaGen Co.
• Ferring group of companies
• Halotech DNA
• Merck KGaA
• MotilityCount
• SCSA Diagnostics, Inc
• Vitrolife
• Zydus Healthcare Limited

Key Questions Answered in This Report

• 1.How big is the male infertility market?
• 2.What is the future outlook of the male infertility market?
• 3.What are the key factors driving the global male infertility market?
• 4.Which region accounts for the largest male infertility market share?
• 5.Which are the leading companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Male Infertility Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Test Type

• 6.1 Sperm Agglutination
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 DNA Fragmentation Technique
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Oxidative Stress Analysis
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Computer Assisted Semen Analysis
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Sperm Penetration Assay
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Treatment

• 7.1 Medication
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Assisted Reproductive Technology and Varicocele Surgery
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospitals Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmacies and Drug Stores
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Fertility Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Research Institutes
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Andrology Solutions
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 CaerusBiotech
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 CinnaGen Co.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Ferring group of companies
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Halotech DNA
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Merck KGaA
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 MotilityCount
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 SCSA Diagnostics, Inc
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Vitrolife
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
  • 15.3.10 Zydus Healthcare Limited
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis